Improving reporting of adverse drug reactions: Systematic review

References

• World Health OrganizationInternational drug monitoring: The Role of National Centres Report No: 498Geneva, SwitzerlandWorld Health Organization1972
   Google Scholar
• PirmohamedMJamesSMeakinSGreenCScottAKWalleyTJAdverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patientsBMJ20043297456151915231615
   PubMed Web of Science ®Google Scholar
• LazarouJPomeranzBHCoreyPNIncidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studiesJAMA199827915120012059555760
   PubMed Web of Science ®Google Scholar
• PatelHBellDMolokhiaMSrishanmuganathanJPatelMCarJTrends in hospital admissions for adverse drug reactions in England: analysis of national hospital episode statistics 1998–2005BMC Clin Pharmacol200771917894876
   PubMedGoogle Scholar
• National Confidential Enquiry into Patient Outcome and Death [NCEPOD]For better, for worse? A review of the care of patients who died within 30 days of receiving systemic anti-cancer therapy2008 Cited February 3, 2009. Available from: http://www.ncepod.org.uk/2008sact.htm
   Google Scholar
• HaubenMZhouXQuantitative methods in pharmacovigilance: focus on signal detectionDrug Saf200326315918612580646
   PubMed Web of Science ®Google Scholar
• LokeYKDerrySAronsonJKA comparison of three different sources of data in assessing the frequencies of adverse reactions to amiodaroneBr J Clin Pharmacol200457561662115089815
   PubMed Web of Science ®Google Scholar
• BMA Science and Education department and the BMA Board of ScienceReporting Adverse Drug Reactions: A guide for healthcare professionalsLondonBritish Medical Association2006
   Google Scholar
• StephensMDBIntroductionTalbotJWallerPStephens’ Detection of New Adverse Drug Reactions5th edHoboken, NJJohn Wiley and Sons Ltd20051017
   Google Scholar
• FigueirasAHerdeiroMTPoloniaJGestal-OteroJJAn educational intervention to improve physician reporting of adverse drug reactions: a cluster-randomized controlled trialJAMA200629691086109316954488
   PubMed Web of Science ®Google Scholar
• RosebraughCJTsongYZhouFImproving the quality of adverse drug reaction reporting by 4th-year medical studentsPharmacoepidemiol Drug Saf20031229710112642973
   PubMed Web of Science ®Google Scholar
• WernickeJFFariesDMiltonDWeyrauchKDetecting treatment emergent adverse events in clinical trials: a comparison of spontaneously reported and solicited collection methodsDrug Saf200528111057106316231957
   PubMed Web of Science ®Google Scholar
• Morrison-GriffithsSWalleyTJParkBKBreckenridgeAMPirmohamedMReporting of adverse drug reactions by nursesLancet200336193661347134812711472
   PubMed Web of Science ®Google Scholar
• LindquistMStahlMBateAEdwardsIRMeyboomRHA retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international databaseDrug Saf200023653354211144660
   PubMed Web of Science ®Google Scholar
• GouldALPractical pharmacovigilance analysis strategiesPharmacoepidemiol Drug Saf200312755957414558179
   PubMed Web of Science ®Google Scholar
• BanksDWooEJBurwenDRPerucciPBraunMMBallRComparing data mining methods on the VAERS databasePharmacoepidemiol Drug Saf200514960160915954077
   PubMed Web of Science ®Google Scholar
• van PuijenbroekEPBateALeufkensHGLindquistMOrreREgbertsACA comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactionsPharmacoepidemiol Drug Saf200211131011998548
   PubMed Web of Science ®Google Scholar
• McGettiganPGoldenJConroyRMArthurNFeelyJReporting of adverse drug reactions by hospital doctors and the response to interventionBr J Clin Pharmacol1997441981009241104
   PubMed Web of Science ®Google Scholar
• CastelJMFiguerasAPedrosCLaporteJRCapellaDStimulating adverse drug reaction reporting: effect of a drug safety bulletin and of including yellow cards in prescription padsDrug Saf200326141049105514583065
   PubMed Web of Science ®Google Scholar
• ClarksonAInglebyEChoonaraIBryanPArlettPA novel scheme for the reporting of adverse drug reactionsArch Dis Child200184433733911259235
   PubMed Web of Science ®Google Scholar
• NaranjoCABustoUSellersEMA method for estimating the probability of adverse drug reactionsClin Pharmacol Ther19813022392457249508
   PubMed Web of Science ®Google Scholar
• BarrowPWallerPWiseLComparison of hospital episodes with ‘drug-induced’ disorders and spontaneously reported adverse drug reactionsBr J Clin Pharmacol200661223323716433879
   PubMed Web of Science ®Google Scholar
• BousquetCHenegarCLouetALDegouletPJaulentMCImplementation of automated signal generation in pharmacovigilance using a knowledge-based approachInt J Med Inform2005747–856357115955732
   PubMed Web of Science ®Google Scholar
• MacedoAFMarquesFBRibeiroCFTeixeiraFCausality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panelPharmacoepidemiol Drug Saf2005141288589016059869
   PubMed Web of Science ®Google Scholar
• LataPFMainhardtMJohnsonCAImpact of nurse case manager-pharmacist collaboration on adverse-drug-event reportingAm J Health Syst Pharm200461548348715018225
   PubMed Web of Science ®Google Scholar
• HouglandPXuWPickardSMasheterCWilliamsSDPerformance of International Classification Of Diseases, 9th Revision, Clinical Modification codes as an adverse drug event surveillance systemMed Care200644762963616799357
   PubMed Web of Science ®Google Scholar
• AspinallMBWhittleJAspinallSLMaherRLJrGoodCBImproving adverse-drug-reaction reporting in ambulatory care clinics at a Veterans Affairs hospitalAm J Health Syst Pharm200259984184512004462
   PubMed Web of Science ®Google Scholar
• GreenhillLLVitielloBFisherPComparison of increasingly detailed elicitation methods for the assessment of adverse events in pediatric psychopharmacologyJ Am Acad Child Adolesc Psychiatry200443121488149615564818
   PubMed Web of Science ®Google Scholar
• SomersAPetrovikMRobaysHBogaertMReporting adverse drug reactions on a geriatric ward: a pilot projectEur J Clin Pharmacol20035870771412610749
   PubMed Web of Science ®Google Scholar
• JhaAKKupermanGJTeichJMIdentifying adverse drug events: development of a computer-based monitor and comparison with chart review and stimulated voluntary reportJ Am Med Inform Assoc1998533053149609500
   PubMed Web of Science ®Google Scholar
• DormannHMuth-SelbachUKrebsSIncidence and costs of adverse drug reactions during hospitalisation: computerised monitoring versus stimulated spontaneous reportingDrug Saf200022216116810672897
   PubMed Web of Science ®Google Scholar
• DormannHCriegee-RieckMNeubertAImplementation of a computer-assisted monitoring system for the detection of adverse drug reactions in gastroenterologyAliment Pharmacol Ther200419330330914984377
   PubMed Web of Science ®Google Scholar
• HopeCOverhageJMSegerAA tiered approach is more cost effective than traditional pharmacist-based review for classifying computer-detected signals as adverse drug eventsJ Biomed Inform2003361–2929814552850
   PubMed Web of Science ®Google Scholar
• HaffnerSvonLNWirthSThurmannPADetecting adverse drug reactions on paediatric wards: intensified surveillance versus computerised screening of laboratory valuesDrug Saf200528545346415853446
   PubMed Web of Science ®Google Scholar
• NeubertADormannHWeissJAre computerised monitoring systems of value to improve pharmacovigilance in paediatric patients?Eur J Clin Pharmacol2006621195996517021890
   PubMed Web of Science ®Google Scholar
• EU-ADR: FP7 Multi-national project to integrate electronic health care records for the early detection and investigation of adverse drugs events2009 Accessed on January 28, 2009. Available from: http://www.euadr-project.org/
   Google Scholar